566 related articles for article (PubMed ID: 16085325)
1. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
Onat A; Hergenç G; Sari I; Türkmen S; Can G; Sansoy V
Am J Hypertens; 2005 Mar; 18(3):409-16. PubMed ID: 15797662
[TBL] [Abstract][Full Text] [Related]
3. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.
Onat A; Hergenç G; Keleş I; Doğan Y; Türkmen S; Sansoy V
Metabolism; 2005 Jun; 54(6):800-8. PubMed ID: 15931618
[TBL] [Abstract][Full Text] [Related]
4. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
[TBL] [Abstract][Full Text] [Related]
5. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
[TBL] [Abstract][Full Text] [Related]
6. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I
Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
[TBL] [Abstract][Full Text] [Related]
7. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
8. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
DECODE Study Group
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
[TBL] [Abstract][Full Text] [Related]
11. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.
Hokanson JE; Austin MA
J Cardiovasc Risk; 1996 Apr; 3(2):213-9. PubMed ID: 8836866
[TBL] [Abstract][Full Text] [Related]
12. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
Suadicani P; Hein HO; Gyntelberg F
Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.
Ko GT; Chan JC; Chow CC; Yeung VT; Chan WB; So WY; Ma RC; Ozaki R; Cockram CS
Acta Diabetol; 2003 Jun; 40(2):80-4. PubMed ID: 12861405
[TBL] [Abstract][Full Text] [Related]
16. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study.
Jónsdóttir LS; Sigfússon N; Gudnason V; Sigvaldason H; Thorgeirsson G
J Cardiovasc Risk; 2002 Apr; 9(2):67-76. PubMed ID: 12006913
[TBL] [Abstract][Full Text] [Related]
17. Moderate and heavy alcohol consumption among Turks: long-term impact on mortality and cardiometabolic risk.
Onat A; Hergenç G; Küçükdurmaz Z; Uğur M; Kaya Z; Can G; Yüksel H
Turk Kardiyol Dern Ars; 2009 Mar; 37(2):83-90. PubMed ID: 19404028
[TBL] [Abstract][Full Text] [Related]
18. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Onat A; Can G; Hergenç G
Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
[TBL] [Abstract][Full Text] [Related]
20. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
